chrisvoncsefalvay/vaers-outcomes huggingface dataset:
2 weeks after my second vaccine shot, I experienced heart palpitations, which I rarely/never experience. The palpitations were strong, and particularly when I was lying down and breathing deeply. They lasted for about 7 days. On day 3 I went to my primary care doctor and he confirmed them on in-office ECG. There was no pain or other symptoms. I was not feeling unusually stressed or anything. I continued to perform my regular moderate- and high-intensity exercise program (3-5 days/week) and it appears to have no effect on my symptoms.
Administered vaccine that was stored at temperature between -80 degree F to -84 degree F; Administered vaccine that was stored at temperature between -80 degree F to -84 degree F; This spontaneous case was reported by a nurse and describes the occurrence of POOR QUALITY PRODUCT ADMINISTERED (Administered vaccine that was stored at temperature between -80 degree F to -84 degree F) and PRODUCT STORAGE ERROR (Administered vaccine that was stored at temperature between -80 degree F to -84 degree F) in a 68-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 076C21A) for COVID-19 vaccination.     No Medical History information was reported.    On 02-Nov-2021 at 1:26 PM, the patient received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) .25 milliliter. On 02-Nov-2021 at 1:26 PM, the patient experienced POOR QUALITY PRODUCT ADMINISTERED (Administered vaccine that was stored at temperature between -80 degree F to -84 degree F). On an unknown date, the patient experienced PRODUCT STORAGE ERROR (Administered vaccine that was stored at temperature between -80 degree F to -84 degree F). At the time of the report, POOR QUALITY PRODUCT ADMINISTERED (Administered vaccine that was stored at temperature between -80 degree F to -84 degree F) and PRODUCT STORAGE ERROR (Administered vaccine that was stored at temperature between -80 degree F to -84 degree F) outcome was unknown.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   No concomitant medication information was provided. The vial undergone temperature excursions for 1 month. The vial was in frozen state at the time of the excursion (Vials in question stored in a super cold Freezer) and minimum reached temperatures was negative 82 degrees Fahrenheit. The patient was given dose from vial that was stored in an ultracold freezer which was colder than it should have been. The vial moved from freezer to refrigerator on 19-Nov-2021, it was a day when the Moderna Covid-19 vials went from the super cold freezer to the refrigerator. The vials were returned to the freezer/refrigerator, or maintained at room temperature. The reporter stated that total 70 vials were still in the ultra cold freezer and 8 vials were in the refrigerator. No vaccine state changes were noticed. The vaccine was never refrozen. None of the vials were punctured. No Previous temperature excursions was reported.  Total 280 patients received Moderna Covid 19 stored at minus 82 degrees Fahrenheit. The patient was administered vaccine that was stored at temperature between minus 80 degree F to minus 84 degree F. No treatment medication information was provided.   This case was linked to MOD-2021-402935 (Patient Link).
I just had an upper chest pain; it was kind of like a shock; Inflammation; I am feeling it like in my breast bone where my sternum meets the breast bone; This is a spontaneous report from a contactable consumer (patient). A 42-year-old female patient received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE; Lot Number: EN6203; Expiration Date: 30Jun2021), via an unspecified route of administration on 02Mar2021 at 09:30 as dose 1, single for COVID-19 immunization. No other patient's relevant medical history and concomitant medications/other products were not reported. Patient wanted to ask about a side effect that might be experienced by the patient but not sure. On 03Sep2021 at 06:00 (reported as yesterday), the patient had an upper chest pain and it went away. It happened about a few more times and it was kind of like a shock. Now, the patient was feeling like in her breast bone where her sternum meets the breast bone. The patient had inflammation as a side effect of the vaccine. The patient wanted to know why he would feel like that pain. No treatment was received by the patient for these events. The outcome of chest pain was recovered in Mar2021 while the outcome of other events was unknown at the time of report. It was reported as no for the investigation assessment.   No follow-up attempts are possible. No further information is expected.
Client reports that a few hours after receiving the Typhoid vaccine she started to feel dizzy and like she was going to "pass out". She also reports feeling feverish with chills. Client reports that she stayed at a store for over 2 hours because she felt too dizzy and weak to walk to her car. Client did not know if she was running a fever because she did not have a thermometer available to check her temp.
This spontaneous report as received from a certified medical assistant refers to an unspecified patients of unknown age and gender. Medical history, concurrent conditions and concomitant medications were unknown. On an unknown date, the patients were vaccinated with improperly stored ROTATEQ suspension 2, (strength, lot #, dose and frequency were not reported). No adverse effects reported. The outcome of the events was unknown. No product quality complaint (PQC) was involved. There was no additional information to report. This is one of several reports received from the same reporter. Additional information has been requested.
Tdap given in left deltoid.  Then Gardasil was given in right deltoid.  Then Menactra was given in right deltoid.  Immediately after Menactra given in right deltoid, pt became unresponsive to vaccine administrator. Patient's eyes were rolled back in his head and arms were twitching bilaterally.  After 30 seconds, the patient stopped twitching and his eye focused.  The examiner was called into the room approximately 1 minute after the seizure activity began and the patient was responsive.
It got harder to swallow food and drink not due to pain but muscle weakness but I did have a slight sore throat. Then at about 2:00 PM after I woke up I had lost my voice and when I try to talk or if I cough it is very hard to get air out it almost feels like my throat is swollen and a heavy pressure on my chest or lungs(when I take a breath my air movement is good) it is just when I talk or cough. My throat does not bother meat all any more today.  I have not seen a Dr. as of yet but I will go in if I do not get better in the next day or two or instructed by you.
Information has been received from a registered nurse concerning a 4 year old white male patient with a concurrent condition of Asthma who on 05/16/2000 was vaccinated subcutaneously in the right arm with a 0.5ml first dose of varicella virus vaccine live.  There was no concomitant medication.  On 03/22/2004, the patient developed varicella (previously reported as presented to the office with less than 30 lesions).  The physician noted "more lesions were erupted as he watched the child".  There was no treatment required.  There were no laboratory diagnostic tests performed.  The outcome was recovered.  Unspecified medical attention was sought.  There was no product quality compliant involved.  No further information has been requested.
redness and induration at the injection site; redness and induration at the injection site; nurse gave a patient 0.1 ML of IPOL instead of Tubersol; Initial information received on 19-Aug-2019 regarding an unsolicited valid non-serious case received from a nurse.  This case is linked to case 2019SA234233 (same reporter).  This case involves a 12 years old male patient who experienced redness and induration at the injection site, while he received vaccine IPV (VERO) [IPOL] and instead of TUBERCULIN TEST [TUBERSOL].  The patient's past medical history, medical treatment(s), vaccination(s) and family history were not provided.   On 14-Aug-2019, the patient received a 0.1 ml dose of suspect IPV (VERO) (lot number: P1E701M, expiry date: 09-Nov-2020) via intradermal route in the left forearm instead being tested with Tuberculin test  On an unknown date, the patient had redness and induration at the injection site (vaccination site erythema) and (vaccination site induration) (unknown latency) following the administration of IPV (VERO).  It was an also a case of actual medication error due to wrong product administered (nurse gave a patient 0.1 ml of IPOL instead of TUBERSOL).  Lab data was not reported.  Final diagnosis was vaccination site erythema and vaccination site induration.   It was not reported if the patient received a corrective treatment.  The patient outcome was reported as unknown for both the events.  This suspected adverse reaction report is submitted and classified as a medication error solely and exclusively to ensure the marketing authorization holder's compliance with the requirements set out in Directive 2001/83/EC and Module VI of the Good Pharmacovigilance Practices. The classification as a medical error is in no way intended, nor should it be interpreted or construed as an allegation or claim made by the marketing authorization holder that any third party has contributed to or is to be held liable for the occurrence of this medication error.  List of document held by sender: none.
Patient began having feelings of sternal chest pain, acute onset of cough, feeling warm throughout body, and c/o headache after approximately 25-30 min after administration of vaccine. patient was on 30 min observation for previous hx of penicillin allergy. RN obtained vital signs, called for MD assistance, obtained blood sugar, gave baby aspirin per MD's order, called 911 for transport to ED to r/o possible MI, patient refused 911 assistance AMA signed for paramedics patient drove away from clinic for refusal of treatment
Patient was administered expired Daptacel with no reported adverse event; Initial information received on 03-Aug-2023 regarding an unsolicited valid  non-serious case received from a other health professional.  This case involves a 2 years old male patient who was administered expired Diphtheria-15/Tetanus/5 Ac Pertussis Vaccine [Daptacel] with no reported adverse event.  The patient's past medical history, medical treatment(s), vaccination(s) and family history were not provided.  Concomitant medications included PNEUMOCOCCAL VACCINE CONJ 7V (CRM197) (PREVNAR) for Immunisation; and HIB VACCINE CONJ (TET TOX) (ACTHIB) for Immunisation.  On 19-Jul-2023, the patient received 0.5 ml of suspect Diphtheria-15/Tetanus/5 Ac Pertussis Vaccine Suspension for injection (Strength: Standard) (Frequency: once) (lot number: C5893AA; Expiry date: 21-Jun-2023) via intramuscular route in the left thigh for immunization.  On 19-Jul-2023, the patient was administered expired Diphtheria-15/Tetanus/5 Ac Pertussis Vaccine [Daptacel] with no reported adverse event (expired product administered) (Latency: same day).  It was reported, Caller would like to know if there is any information to support the use of the expired product? Caller would like to know if there is any safety information on a repeat dose of the Daptacel product in such a short interval.  Action taken: not applicable.  Outcome: Unknown   This suspected adverse reaction report is submitted and classified as a medication error solely and exclusively to ensure the marketing authorization holder's compliance with the requirements set out in the Directive 2001/83/EC and Module VI of the Good Pharmacovigilance Practices. The classification as a medical error is in no way intended, nor should it be interpreted or construed as an allegation or claim made by the marketing authorization holder that any third party has contributed to or is to be held liable for the occurrence of this medication error.
On 4/28/00 the pt experienced a fever of 102.4 and a sore left arm. On 4/29/00 the pt experienced a fever of 103.6, vomiting for 2 days. Fever through 5/1/00, recovered by 5/2/00.
Narrative: COVID infection following COVID vaccine series and after previous COVID infection 01/14, Pfizer, dose #1 02/04, Pfizer dose #2 08/04 pt cc: cough, rhinorrhea, fatigue, headache, myalgias, nocturnal dyspnea exposure: unknown 08/05 COVID swab, result: detected 08/05 - 08/12 pt's symptoms continued 08/05 CXR impression: Chronic right pleural effusion and atelectatic changes in the right lung base, stable from previous examination. The remaining visualized lung fields are clear. 08/09 pt admitted in ED dx: COVID PNA LOS: 1 day 08/09 TROPONIN I 0.120 08/09 BNP 2251 08/09 CXR impression: The heart shadow is normal in size. Small right pleural effusion and adjacent atelectasis/consolidation is stable from prior. No new consolidation or pneumothorax. Note that groundglass opacities, as can occur with viral pneumonia, may not be visible on plan film 08/10 CT Chest impression: Scattered bilateral patchy groundglass opacities and groundglass nodules, left greater than right, can be seen in COVID-19 pneumonia. Small right pleural effusion. Mildly progressive right middle lobe consolidation. Recommend follow-up. 08/12 Clinically resolved 08/12 SARS-COV-2 LINGEAGE result: B.1.617.2 08/12 SARS-COV-2 clade results: 21A DELTA 08/26 COVID swab, result detected
Problems with vision; This case was reported by a physician via call center representative and described the occurrence of abnormal vision in a 51-year-old female patient who received Herpes zoster (Shingrix) for prophylaxis.   On an unknown date, the patient received Shingrix. On an unknown date, unknown after receiving Shingrix, the patient experienced abnormal vision. On an unknown date, the outcome of the abnormal vision was unknown.   It was unknown if the reporter considered the abnormal vision to be related to Shingrix.  Additional details were reported as follows: The age at vaccination was not reported. The patient experienced problems with vision after receiving Shingrix.  The reporter did not know if the patient received one or two doses neither when she received the doses and when the symptoms started.  The reporter did not consent to follow up.
The day after 2nd dose I had fever and fatigue. Fatigue resolved slightly, but by June I was far more fatigued than usual. Was diagnosed with large B cell lymphoma this fall. Just finished R-CHOPs treatment.  I was advised to report this association. Have no idea whether they are related.
Was very dizzy the following 2-3 days. Developed Shingles on left side of face the same week, which grew into bigger blisters the next week, spreading to the chin and the right side slowly. (about 20 blisters on face now). The ones on left are crusting now, but, painful blisters still exist on the right. (Had one doctor visit so far).
Achy, weak, dizzy, chest pain, headache, shaky, twitching, fever 100.4 - 101.6, 4 mo old whiplash pain renewed as if fresh, severe arm pain, chilled, swelling of right arm for 2 days. Has triggered OCD & depression episode as of 9-25-09.
Soreness and Rash at injection site Moderate Flu like symptoms including fatigue, vomiting, total body aches No fever  Mild headache
rt lower extremity monoplegia likely transverse myelitis of spinal cord or polio
Grandmother of patient called to Vaccination Information Line to report an adverse event after receiving vaccines on 07JUN2017. Grandmother reported after her grandson received the following vaccines, Hepatitis A, DTaP/Tdap, Hib, and Polio on 07JUN2017 he had a cold, runny nose, and an "eye thing". The grandmother was not able to provide the exact date this occurred except that it was after the vaccines and it occurred in 2017. Additionally, the grandmother could not recall which eye was affected. The child was seen by a doctor and was treated with TYLENOL and eye drops. All symptoms resolved on an unknown date. The names the vaccines are not known. No additional information was provided.
Information has been received from a consumer concerning her first 6 year old child who was vaccinated with his first dose of MMR II. Subsequently the patient was diagnosed with autism and had been in special education classes. The patient received different unspecified vaccines including MMR II. The mother did not want to provide the names of other vaccines that the patient received along with MMR II because she did not have the information available with her "right now". The mother added that the patient experienced high fever as well after receiving MMR II. The patient had sought unspecified medical attention. At the time of reporting the patient's autism and high fever persisted. Upon internal review, autism was considered to be an other important medical event. This is one of two reports from the same source. No further information is available.
Severe injection site pain, muscle pain/body aches, fatigue, fever, chills, and headache. Headache persisted for days after.
covid vaccine was mixed with incorrect amount of diluent , which lead to the patient receiving a more concentrated dose of the vaccine. Patient was monitored for a longer time. No adverse outcomes from dose
Moderna COVID 19 Vaccine EUA  Admitted for TIA, hyponatremia, confusion and dysequilibrium
Pt found pregnant 3 Aug 07. Pt is estimated to have been pregnant since on or about 01 Jul 07.
Mother reported rash on injection site, see by Dr. who reports she does have localized swelling, warmth and erythema on injection site, no further complications noted.
This spontaneous report was received from a healthcare worker and refers to an unspecified number of patients of unknown age and gender. There was no information about the patient's concurrent conditions, concomitant therapies or medical history provided. On unknown dates, the patients were vaccinated with improperly stored doses of GARDASIL 9 lot # L004014, expiration date 04-MAR-2017; lot # L045711, expiration date 08-MAY-2017; lot # L016428, expiration date 30-JUL-2017 (dose and route of administration were not reported). The administered doses experienced the temperature excursion of 32 degrees Fahrenheit for 63 days. The temperature excursion was detected by a data logger. There was no previous temperature excursion reported. No adverse effects were reported. This is one of several reports received from the same reporter. Additional information has been requested.
Patient complained of great fatigue 3 hours after receiving vaccine with sore left arm. Fatigue continued through night. (L) arm soreness persistent. Cannot sleep on left arm. Difficulty lifting (L) arm over head without pain. No relief with meloxicam, which she has for knee problems. Saw family doctor today - to see orthopedist for knee pain & also pain in (L) arm occurring after flu vaccines. (L) arm slightly puffy for 2 weeks after injection - using ice - not puffy now.
Baby was to be given Hep B vaccination. Was inadvertently given Tdap because the medication syringes look very similar. Pics are available.
Patient stated she was feeling dizzy and cold. Her pulse felt strong and regular but she was cold to the touch.  She was given water and laid down while being monitored. After approximately 20 minutes after the event she said she was feeling better and left without assistance.
Redness to LA where immunizations were given. Took MOTRIN, no relief. Went to ER & Dx with cellulitis. Rx'd 10 day tx with abx clindamycin.
Patient experienced unusual soreness, inflammation and fever at injection site that is three to four inches in diameter, low grade fever starting Sat (highest 100) that lasted over 24 hours (fever free as of 10/14/19).
Patient received MMR and Influenza vaccines on her left thigh on Oct 12, 2020. She developed swelling and bruise at site of vaccines No erythema noted. Induration present
within a day I got tinnitus. I hadn't had it before so it was very noticeable. I looked it up and it seemed like it might just go away. after a few days it didn't so I looked it up again and seemed like some people got it after the vax but it might get better. By 3/17 it was still bad and I checked with my primary care about whether I should get the 2nd vax or not, and she said I should.
Administration of an invalid dose; This spontaneous case was reported by a nurse and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (Administration of an invalid dose) in a 20-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 031M21A) for COVID-19 vaccination.     No Medical History information was reported.    On 22-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 22-Mar-2021, the patient experienced EXPIRED PRODUCT ADMINISTERED (Administration of an invalid dose). At the time of the report, EXPIRED PRODUCT ADMINISTERED (Administration of an invalid dose) had resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown Route) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown Route), the reporter did not provide any causality assessments.   No Concomitant medications were provided No Treatment information provided    This case was linked to MOD-2021-056335 (Patient Link).
This spontaneous report as received from a physician refers to a female patient of unknown age. Medical history included splenectomy. In 2009 (reported as 5 years ago) the patient was vaccinated with a first dose of PNEUMOVAX 23 (dose, route, lot number and expiration date not reported). On 10-NOV-2014 the patient was vaccinated with a second dose of PNEUMOVAX 23 (dose, route, lot number and expiration date not reported). On 11-NOV-2014 the patient experienced severe injection site reactions from elbow to shoulder, further describes as stiff, painful and swollen. The patient sought medical attention. At the time of the report the outcome of the events was not recovered (reported as events remained ongoing). Additional information has been requested.
Mom called stating pt's left upper arm was red, swollen, hot and painful since 8/12/03 in the AM. Advised to apply cool compresses to area, give child children's Motrin every 6 hours for pain and swelling. Agreed to do so. As of 8/14/03 mom states improvement in symptoms. Still recovering as of today 8/14/03.
pain, local swelling, reddness approx 3 in, firm et warm to touch; also felt bump under armpit; denies fever; presented to clinic 27APR93 w/swelling @ site 1" round w/pain lt shoulder armpit;
First 24 hours: pain and swelling at site of injection  and then spread to arm pit area as well.  46 hours after shot: sudden chills and shakes, very severe, but lasted only 45 minutes
Breakthrough case admission after 4 vaccines Pfizer 1/8/21 lot# EL0140;  Pfizer 1/29/21 lot# EL9261;  Pfizer 11/2/21 lot# EW0186;  Pfizer 9/21/22 lot# Gh9693
Worsening ringing in the ears; This spontaneous case was reported by a consumer and describes the occurrence of TINNITUS (Worsening ringing in the ears) in a 57-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     The patient's past medical history included Tinnitus.    On 22-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 23-Mar-2021, the patient experienced TINNITUS (Worsening ringing in the ears). At the time of the report, TINNITUS (Worsening ringing in the ears) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       Concomitant medication list was not provided. Treatment information was not provided.
PATIENT WAS EXPECTED TO RECEIVE A HIGH DOSE FLU VACCINE ON SEPTEMBER 9, 2021 BUT RECEIVED A DOSE OF COVID PFIZER INSTEAD. AFTER THE INCIDENT THE PATIENT STATED THAT SHE ALREADY RECEIVED A 2 DOSES OF MODERNA IN THE PAST